HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Delphine Trousse Xavier Benoît D’Journo Christophe Doddoli Roger Giudicelli Pierre Antoine Fuentes Pascal Alexandre Thomas Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Trousse, D. Articles by Thomas, P. A. Search for Related Content PubMed PubMed Citation Articles by Trousse, D. Articles by Thomas, P. A. Related Collections Lung - cancer

Multifocal T4 non-small cell lung cancer: a subset with improved prognosis

University of The Mediterranean Assistance Publique Hôpitaux de Marseille Sainte Marguerite Hospital, Marseille, France

Received 16 June 2007; received in revised form 19 September 2007; accepted 27 September 2007.

^_* Corresponding author. Address: Department of Thoracic Surgery, Ste Marguerite Hospital-CHU Sud, 270 Bd Ste Marguerite, 13274 Marseille Cedex 9, France. Tel.: +33 491 744 680; fax: +33 491 744 590. (Email: pathomas{at}ap-hm.fr).

Objective: T4-disease for non-small cell lung cancer (NSCLC) includes different conditions: mediastinal invasion, neoplastic pleural cytology, and multifocal disease in the same lobe; regarding the last category, no strict criteria allow to differentiate satellite nodules from synchronous multiple primary tumours. Methods: Retrospective study of 56 patients who underwent a complete resection from 1985 to 2006 of a NSCLC graded pT4N0 due to multifocal disease. A small nodule (<1 cm) closed to the primary tumour, in a same pulmonary segment with an identical histology was considered as a satellite nodule (pT4sn). Multiple tumours, sized more than 1 cm, with an identical histology, located in the same lobe but in different segment were considered as synchronous cancers (pT4sc). Results: There were 44 males and 12 females: 35 patients were graded T4sn and 21 patients T4sc. The median age was 62.5 years. The two groups were similar for sex, age, tobacco consumption, ASA score, NYHA, Charlson's index, spirometric parameters, cardiovascular comorbidity and history of previous extra-thoracic malignancies. All had a complete anatomic resection with mediastinal lymphadenectomy. Thirty-day mortality rate was 3.6%. Overall 5-year and 10-year survival rates were 48.2% and 29.9%, respectively. There was a non-significant trend for a worse survival in T4sn group patients when compared to that of T4sc group patients: 42.9% vs 52.3% at 5 years, and 25% vs 34.9% at 10 years (p = 0.62). Conclusions: Multifocal T4 stage IIIB disease is a heterogeneous category where overall prognosis is far better than those of other T4 subgroups. Survival rates associated with pT4sn and pT4sc look roughly similar because of the small size of the subgroups usually submitted to comparison in most series. In the present experience, respective survival figures diverge, suggesting different biological behaviours.

Key Words: Multifocal lung cancer • Multiple primary lung cancer • Intrapulmonary satellite nodule • Multicentric synchronous cancer

This article has been cited by other articles:

				W. N. William Jr, H. Y. Lin, J. J. Lee, S. M. Lippman, J. A. Roth, and E. S. Kim Revisiting Stage IIIB and IV Non-small Cell Lung Cancer: Analysis of the Surveillance, Epidemiology, and End Results Data Chest, September 1, 2009; 136(3): 701 - 709. [Abstract] [Full Text] [PDF]

				A. F. Gazdar and J. D. Minna Multifocal Lung Cancers--Clonality vs Field Cancerization and Does It Matter? J Natl Cancer Inst, April 15, 2009; 101(8): 541 - 543. [Full Text] [PDF]

				F. Farjah, D. E. Wood, T. K. Varghese Jr, R. G. Symons, and D. R. Flum Trends in the Operative Management and Outcomes of T4 Lung Cancer Ann. Thorac. Surg., August 1, 2008; 86(2): 368 - 374. [Abstract] [Full Text] [PDF]